Markets
| Security | Price ▼ | % | Buy | Sell | Target price | Potential |
|---|---|---|---|---|---|---|
| Cara Therapeutics Inc. |
€0.32
15:32 |
-3.510% | 11 | 4 | €4.62 | 1349.498% |
| Brainstorm Cell |
€0.30
01.08.24 |
-1.780% | 2 | 0 | €1.84 | 505.272% |
| Sorrento Therapeutics Inc. |
€0.28
16.06.23 |
- | 0 | 0 | - | - |
| Fortress Biotech Inc. |
€0.27
20.11.23 |
-12.900% | 0 | 0 | - | - |
| Nanthealth Inc. |
€0.26
24.08.23 |
- | 0 | 0 | - | - |
| Calithera Biosciences Inc. |
€0.24
25.05.23 |
- | 0 | 0 | - | - |
| Endologix |
€0.21
02.10.20 |
- | 0 | 0 | - | - |
| Agile Therapeutics Inc. |
€0.21
15.07.23 |
- | 1 | 5 | - | - |
| Glycomimetics Inc. |
€0.20
31.07.24 |
1.230% | 5 | 3 | €7.35 | 3579.479% |
| Infinity Pharmaceuticals Inc. |
€0.19
09.10.23 |
7.360% | 0 | 0 | - | - |
| Akorn Inc. |
€0.17
08.08.20 |
- | 0 | 0 | - | - |
| T2 Biosystems Inc. |
€0.16
20.11.23 |
-44.060% | 0 | 6 | - | - |
| Ziopharm Oncology |
€0.15
31.01.24 |
11.930% | 0 | 0 | - | - |
| Trevena Inc. |
€0.15
01.08.24 |
-15.450% | 2 | 20 | €6.48 | 4192.715% |
| Pieris Pharmaceuticals Inc |
€0.14
19.04.24 |
-2.980% | 0 | 0 | - | - |
| MyMD Pharmaceuticals Inc. |
€0.12
14.02.24 |
1.770% | 0 | 0 | - | - |
| Avenue Therapeutics Inc. |
€0.11
25.04.24 |
22.820% | 1 | 0 | €0.70 | 542.541% |
| Athersys Inc. |
€0.095
20.11.23 |
6.990% | 0 | 0 | - | - |
| Otonomy Inc. |
€0.083
14.04.23 |
- | 0 | 0 | - | - |
| Clovis Oncology Inc. |
€0.077
03.04.23 |
- | 0 | 0 | - | - |
| Bellicum Pharmaceuticals Inc. |
€0.064
05.03.24 |
-9.290% | 0 | 12 | - | - |
| Sientra Inc. |
€0.054
01.03.24 |
0.940% | 0 | 0 | - | - |
| Zosano Pharma Corp. |
€0.050
28.10.22 |
- | 0 | 0 | - | - |
| Avalo Therapeutics Inc. |
€0.041
28.12.23 |
2.500% | 2 | 0 | - | - |
| Surgalign Holdings Inc. |
€0.015
12.07.23 |
-39.530% | 0 | 0 | - | - |
| Endo International |
€0.010
30.04.24 |
-16.670% | 0 | 0 | - | - |
| Genocea Biosciences Inc. |
€0.009
23.12.22 |
- | 1 | 21 | - | - |
| Cas Medical Systems |
-
- |
- | 0 | 0 | - | - |
| Nxstage Medical |
-
- |
- | 0 | 0 | - | - |
| Endocyte Inc. |
-
- |
- | 0 | 0 | - | - |